Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Reed Insider Profile
4 Followers
Kenneth Reed, Director at RedHill Biopharma, holds 3.69M shares in RedHill Biopharma (Ticker: REDIF), holds 3.69M shares in RedHill Biopharma (Ticker: RDHL). Most recently, Kenneth Reed ― shares of RedHill Biopharma on ― for an estimated value of ―.
Kenneth Reed RedHill Biopharma (REDIF)Director
RedHill Biopharma (REDIF)
Director
Not Ranked
Kenneth Reed has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Kenneth Reed holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kenneth Reed
Kenneth Reed's Trading History
RedHill Biopharma
―
―
―
$2.47M
RedHill Biopharma
Aug 30, 2012
Director
Informative Buy
111.82K
$33.29M
List of latest transactions for each holding click on a transaction to see Kenneth Reed's performance on stock
You May Also Like
Kenneth Reed insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Reed?
The percentage of profitable transactions made by Kenneth Reed is ―.
What is the average return per transaction made by Kenneth Reed?
The average return per transaction made by Kenneth Reed is ―.
What stocks does Kenneth Reed hold?
Kenneth Reed holds: REDIF, RDHL stocks.
What was Kenneth Reed’s latest transaction?
Kenneth Reed latest transaction was an Uninformative Buy of ―.
What was Kenneth Reed's most profitable transaction?
Kenneth Reed’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kenneth Reed's role in RedHill Biopharma?
Kenneth Reed's role in RedHill Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.